← All trials
NCT04677712
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 28, 2020
- Primary completion
- Jun 26, 2021
- Completion date
- Sep 2, 2021
- First posted
- Dec 21, 2020
- Last posted
- Aug 21, 2023
- Enrollment
- 48
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Endo PharmaceuticalsLead sponsor
- DeNova ResearchCollaborator
- Endo PharmaceuticalsStudy director
- Investigate MD, LLCCollaborator
- Endo PharmaceuticalsOfficial
- University of California, San DiegoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.